fms样酪氨酸激酶,Flt-1
1)Flt-1fms样酪氨酸激酶
1.The Sensitivity ofFlt-1 Gene of Men of Han Nationality in Northern China to the HiHiLo Training;中国北方汉族男子fms样酪氨酸激酶基因多态性与高住高练低训敏感性的关联性研究
英文短句/例句
1.The name is soluble f-m-s-like tyrosine kinase one?这种蛋白质叫做可溶解fms样酪氨酸激酶一,
2.The Primary Study of the Relationship between Tyrosine Protein Kinase and Salivary Adenoid Cystic Carcinoma酪氨酸蛋白激酶与涎腺腺样囊性癌的关系的初步研究
3.Effects of beta-amyloid protein on expression of tyrosine kinase receptor A in neural stem cellsβ淀粉样蛋白对神经干细胞酪氨酸蛋白激酶A表达的影响
4.Preliminary Research of RAI16 Protein Interacting with Tec Tyrosine Kinase;Tec酪氨酸激酶作用蛋白RAI16的初步研究
5.Expression of receptor tyrosine kinase EphA1 in gastric cancer and its clinicopathological significance受体酪氨酸激酶EphA1 mRNA在胃癌中的表达
6.The Research of Antibody Against Muscle-specific Tyrosine Kinase in Myasthenia Gravis among Chinese;重症肌无力患者酪氨酸激酶抗体的相关研究
7.Tec Tyrosine Protein Kinase Involved in Multidrug Resistance of Hepatocelluar Carcinoma;Tec酪氨酸蛋白激酶参与肝癌多药耐药的研究
8.c-Abl Stabilizes Estrogen Receptor by Phosphorylation and Regulates Its Transcription Activity;c-Abl非受体酪氨酸激酶调节ERα转录活性的研究
9.Study on the Prevalence of Protein Tyrosine Kinase JAK2V617F Mutation in the Western Population;西方人群中蛋白质酪氨酸激酶JAK2~(V617F)突变率研究
10.Expression and Clinical Significance of Receptor Tyrosine Kinase RON in Lung Carcinoma肺癌组织中酪氨酸激酶受体RON的表达及意义
11.Molecular targeted therapies:targeting receptor tyrosine kinases in the treatment of gastric cancer靶向于受体酪氨酸激酶的胃癌分子靶向治疗
12.Tyrosine Kinase Mutation and Acute Myeloid Leukemia with t(8;21)酪氨酸激酶突变与t(8;2急性髓系白血病
13.Advances in the inhibitors of FLT-3 receptor tyrosine kinaseFLT-3受体酪氨酸激酶抑制剂的研究进展
14.Multi-targeted protein tyrosine kinase inhibitor:research advances多靶点蛋白酪氨酸激酶抑制剂的研究进展
15.Advances in the research of multi-target tyrosine kinase inhibitors多靶点抗肿瘤酪氨酸激酶抑制剂的研究开发
16.Expression of receptor tyrosine kinase EphA7 in gastric carcinoma and its clinical significances受体酪氨酸激酶EphA7基因在胃癌中的表达及意义
17.Effect of Receptor Protein-tyrosine Kinases in Tumor Angiogenesis受体酪氨酸激酶在肿瘤血管新生中的作用
18.Progress in research of multi-targeted inhibitors of receptor tyrosine kinase多靶点受体酪氨酸激酶抑制剂的研究进展
相关短句/例句
Fms-like tyrosine kinase-1fms样酪氨酸激酶-1
3)FMS-like tyrosine kinase 3 ligandFMS样酪氨酸激酶3配体
1.Aim:To clone the cDNA ofFMS-like tyrosine kinase 3 ligand(Flt3L) and to construct the prokaryotic expression vector for the Flt3 ligand extracellular domain fused with a His6 tag and express in Escherichia coli(E.目的:构建含组氨酸标签的FMS样酪氨酸激酶3配体(Fms-like tyrosine kinase 3 ligand,Flt3L)胞外域蛋白的原核表达载体,并在大肠杆菌中进行表达。
4)FMS-like tyrosine kinase-3 (FLT-3)FMS样酪氨酸激酶3(FLT-3)
5)fms like tyrosine kinase 4fms样酪氨酸激酶4
1.Objective To investigate the expression of Tiam-1(T lymphoma invasion and metastasis)and Flt-4(fms like tyrosine kinase 4)proteins in thyroid papillary carcinomas and their roles in the development of thyroid carcinoma.目的探讨T淋巴瘤侵袭转移基因(Tiam-1)和fms样酪氨酸激酶4(Flt-4)在甲状腺乳头状癌和正常甲状腺以及腺瘤组织中的表达情况,研究其在甲状腺乳头状癌发生和发展中的作用。
6)c-fms-like tyrosine (kinase)-4c-fms样酪氨酸蛋白激酶4
延伸阅读
酪氨酸蛋白激酶抑制剂分子式:CAS号:性质:一类能抑制蛋白质酪氨酸激酶活性的化合物。酪氨酸蛋白激酶能特异性地将磷酸根转移到蛋白质的酪氨酸残基上使其磷酸化,是许多配体活化的生长因子受体和一些癌基因产物,在肿瘤组织中含量高。酪氨酸蛋白激酶抑制剂可作为ATP与酪氨酸蛋白激酶结合的竞争性抑制剂,也可作为酪氨酸的类似物阻断表皮生长因子受体的肽位点和酪氨酸蛋白激酶的编码,抑制细胞增殖,可望开发为抗肿瘤药物,但对完整细胞没有表现出选择性。